What is CDBT's current dividend yield?

CDBT (China Dasheng Biotechnology Company) yields 2000.00% based on an annual dividend of $2.00 per share at a stock price of $0.10. Dividends are paid quarterly.

How much does $10,000 in CDBT generate in dividends?

$10,000 invested in CDBT at 2000.00% yield generates approximately $200000.00 per year, or $16666.67 per month in dividend income. With DRIP reinvestment, this compounds significantly over time.

How much does $50,000 in CDBT pay in dividends?

$50,000 in CDBT generates approximately $1000000.00 per year at the current 2000.00% yield.

Is CDBT a good dividend stock in 2026?

CDBT pays quarterly dividends with a 2000.00% yield and 50% payout ratio. The 5-year dividend CAGR is 5%. The 50% payout ratio is considered sustainable. This is not financial advice.

Home › Calculator › CDBT Dividend Calculator 2026

CDBT Dividend DRIP Calculator 2026

2000.00% YieldFinancial Services

China Dasheng Biotechnology Company · OTC

Price: $0.10 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD

Annual dividend

$2.00

per share

Forward yield

2000.00%

at current price

1Y div growth

+0%

CAGR

5Y div growth

+0%

CAGR

Payout ratio

50%

Sustainable

Calculator settings

ACCOUNT TYPE

INITIAL INVESTMENT

MONTHLY CONTRIBUTION$0/mo

$0$500$1k$2k

INVESTMENT HORIZON10 years

1y10y20y30y

PRICE GROWTH / YEAR0%

DIVIDEND GROWTH / YEAR0%

DRIP Reinvestment

Auto-reinvest all dividends

Monthly passive income

$13,238,000,776,350,000.00

after 10 years · DRIP ✓

Yield on cost: 1588560093162000%

Annual dividend income

$158,856,009,316,200,000.00

after 10 years

Total dividends: $166798809782.00M

Real Yield · Inflation Adjusted

+1997.2%= 2000.00% yield − 2.8% CPI

iCalculated by subtracting the current 12-month CPI (2.8%) from the forward yield. Yield exceeds inflation — purchasing power is growing.

Portfolio (DRIP)

$166798809782.01M

Portfolio (no DRIP)

$2.01M

DRIP bonus

+$166798809780.00M

Total return

+1667988097820000.0%

📊 See how CDBT actually performed since 2021 →

Real historical prices · DRIP simulation · DCA backtest

Last 5 Years →

Year-by-year projection

DRIP ON ✓ · Roth IRA / ISA

Year	Shares	Annual income	Monthly income	Portfolio value	Yield on cost	Cumul. dividends
1	2,100,000.00	$200,000.00	$16,666.67	$210,000	2000%	$200,000
2	44,100,000.00	$4,200,000.00	$350,000.00	$4,410,000	42000%	$4,400,000
3	926,100,000.00	$88,200,000.00	$7,350,000.00	$92,610,000	882000%	$92,600,000
4	19,448,100,000.00	$1,852,200,000.00	$154,350,000.00	$1,944,810,000	18522000%	$1,944,800,000
5	408,410,100,000.00	$38,896,200,000.00	$3,241,350,000.00	$40,841,010,000	388962000%	$40,841,000,000
6	8,576,612,100,000.00	$816,820,200,000.00	$68,068,350,000.00	$857,661,210,000	8168202000%	$857,661,200,000
7	180,108,854,100,000.00	$17,153,224,200,000.00	$1,429,435,350,000.00	$18,010,885,410,000	171532242000%	$18,010,885,400,000
8	3,782,285,936,100,000.00	$360,217,708,200,000.00	$30,018,142,350,000.00	$378,228,593,610,000	3602177082000%	$378,228,593,600,000
9	79,428,004,658,100,000.00	$7,564,571,872,200,000.00	$630,380,989,350,000.00	$7,942,800,465,809,999	75645718722000%	$7,942,800,465,800,000
10	1,667,988,097,820,099,800.00	$158,856,009,316,200,000.00	$13,238,000,776,350,000.00	$166,798,809,782,010,000	1588560093162000%	$166,798,809,782,000,000

Portfolio growth: DRIP vs No DRIP

Annual dividend income growth

💡 What-if scenarios

Click to apply scenario to the calculator

☕

Daily coffee money

+$150/mo for 15 years

$809974367951295232.00M

$64,283,679,996,134,550,000,000.00/month income

DCA bonus vs no DCA: +$128751182121778768.00M

📱

Skip one gadget/mo

+$100/mo for 20 years

$3.132739515572672e+24M

$248,630,120,283,545,470,000,000,000,000.00/month income

DCA bonus vs no DCA: +$3.505552211031598e+23M

🚀

Serious wealth mode

+$500/mo for 25 years

$1.8521236304540382e+31M

$1,469,939,389,249,236,800,000,000,000,000,000,000.00/month income

DCA bonus vs no DCA: +$7.158514645313157e+30M

🎯 When CDBT pays your bills

Year your monthly dividend income covers each expense (based on current settings)

📺

Netflix

$18/month

✓ Year 1

🎵

Spotify

$11/month

✓ Year 1

📱

Phone bill

$60/month

✓ Year 1

🛒

Gas & groceries

$300/month

✓ Year 1

🚗

Car payment

$500/month

✓ Year 1

🏠

Rent (avg US)

$1,500/month

✓ Year 1

🏝️

Financial freedom

$5,000/month

✓ Year 1

Share your CDBT snowball 📈

$10,000 in CDBT → $166798809782.01M in 10 years · $13,238,000,776,350,000.00/month

Post on X

About China Dasheng Biotechnology Company (CDBT) — Dividend Analysis 2026

China Dasheng Biotechnology Company, together with its subsidiaries, engages in the production, marketing, and distribution of bacteria based products used as additives for livestock feed and crop cultivation in the People's Republic of China. It provides artificial microorganisms (AM) and high-efficiency microorganism (HM) based biological bacterium blends; and biological preservatives. The company offers AM/HM bacteria based additives for crops, including Bulgaria lactobacillus, beer microzyme, and dark red spirilla used to increase the beneficial microorganism colonies in soil; inhibit the reproduction of harmful fungi and putrefactive bacteria; and to improve nutrient absorption and reduce crop and livestock diseases. It also provides AM/HM bacteria based additives for livestock feed, which softens the livestock feed and restrain the growth and reproduction of pathogenic bacteria, as well as supplies beneficial nutriments, including organic acid, vitamins, enzyme, antibiotics, mycelium protein, and other growth-enhancing substances that balance the nutrients in the feed. In addition, the company offers FGW bacterial based preservatives that preserve animal specimens for scientific research; and preserve the freshness for agricultural produce. Further, it provides bacteria based fertilizer for application on plants, such as vegetable and fruit leaves. Additionally, China Dasheng Biotechnology Company engages in residential and commercial real estate investment. The company was formerly known as Max Nutrition, Inc. and changed its name to China Dasheng Biotechnology Company in March 2008. China Dasheng Biotechnology Company is based in Lanzhou, China.

Is CDBT a good dividend investment in 2026?

CDBT offers a 2000.00% forward yield with a 50% payout ratio. Strand Safety Score: 15/100 (Critical Risk). The 5-year dividend CAGR of 0% is modest — investors should weigh current income against growth alternatives.

CDBT DRIP calculator — what's the difference?

With DRIP on a $10,000 investment over 10 years, your CDBT portfolio grows to $166798809782.01M vs $2.01M without reinvestment. This is the compound interest effect in action.

CDBT dividend growth history & forecast

CDBT has grown its dividend by 0% over the last year and 0% annually over 5 years. At this pace, an investor who holds for 10+ years will see their yield on cost grow substantially above the current 2000.00%.

Compare CDBT with similar stocks

⚖️ Compare CDBT vs SCHD →

Expert Reviewed byVictor StrandVERIFIED

This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.

📬

Get Your Full CDBT DRIP Report by Email

We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.

Free forever. No spam. Unsubscribe anytime.

Ready to invest? Open CDBT position with:

🛡️ Dividend Safety Analysis

Strand Safety Score™ — CDBT

Proprietary model · FCF Coverage (40) · Debt Leverage (30) · Earnings Momentum (30)

/100

Critical Risk

Cash Flow Coverage-0.0× coverage

0 / 40 pts

0/40

Company generates negative FCF ($-233,550) — borrowing to pay dividends

Debt Leverage0.0× Debt/EBITDA

0 / 30 pts

0/30

Company not generating EBITDA — debt servicing risk is elevated

Earnings Momentum-0.0B → +0.0B → -0.0B

15 / 30 pts

15/30

Net income grew in the latest year — positive but trend is unconfirmed

OVERALL ASSESSMENT

High risk of dividend cut — weak fundamentals across multiple factors.

STRAND SCORE

/100

Strand Safety Score™ is proprietary to DividendFlow. Inputs: FCF, Debt/EBITDA, Net Income from SEC filings via FMP. Not financial advice. N/A for ETFs, pre-revenue companies, and tickers without income statements.

🌍 CDBT Yield by Country & Account Type

Real after-tax yield depends on where you live and how you hold CDBT.

Gross yield

2000.00%

Tax rate

15.00%

After-tax yield

1700.00%

Real yield (−CPI)

1697.20%

Account/Country	Tax Rate	After-tax Yield	Real Yield	$10K Annual Income
🇺🇸 Roth IRA / 401k	0%	2000.00%	1997.20%	$200,000 / yr
🇺🇸 US Taxable (15%) ✓	15%	1700.00%	1697.20%	$170,000 / yr
🇺🇸 US Taxable (20%)	20%	1600.00%	1597.20%	$160,000 / yr
🇬🇧 UK ISA	0%	2000.00%	1997.20%	$200,000 / yr
🇬🇧 UK Taxable	8.75%	1825.00%	1822.20%	$182,500 / yr
🇨🇦 TFSA	0%	2000.00%	1997.20%	$200,000 / yr
🇨🇦 CA Taxable	25%	1500.00%	1497.20%	$150,000 / yr
🇦🇺 Super (pension)	15%	1700.00%	1697.20%	$170,000 / yr
🇦🇺 AU Taxable	30%	1400.00%	1397.20%	$140,000 / yr
🇩🇪 DE Taxable	26.375%	1472.50%	1469.70%	$147,250 / yr
🇫🇷 FR Taxable	30%	1400.00%	1397.20%	$140,000 / yr

Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.

🎯 CDBT Income Goal & Break-Even

Dividend Break-Even

1yr

Years for dividends to fully repay your CDBT investment of $0.10/share (🇺🇸 US Taxable (15%) · 15.00% tax)

$10K invested · 10 Years

Dividends earned (DRIP)

$35704672266.23M

Lost to inflation (2.8% CPI)

−$2.5K

Real purchasing power gain

$35704672266.23M

12-month CPI (US BLS via FMP economic-indicators).

How much do I need to invest in CDBT for:

Shares needed

14,118

Capital required

$1,412

Monthly income

$2,000

Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).

📅 CDBT Dividend Payment Schedule

CDBT pays quarterly — 4 times per year. Next ex-div: TBD.

Jan

Feb

Mar

💰

Apr

May

Jun

💰

Jul

Aug

Sep

💰

Oct

Nov

Dec

💰

10 shares

$4.25 / payment

$17.00 / year after tax

100 shares

$42.50 / payment

$170.00 / year after tax

1,000 shares

$425.00 / payment

$1700.00 / year after tax

📊 CDBT vs Financial Services Benchmarks

How CDBT compares to typical Financial Services averages.

Benchmark: Financial Services

Dividend Yield▲+1997.10% vs sectorBetter

CDBT

2000.00%

avg

2.90%

5Y Dividend CAGR▼-7.10% vs sectorBelow avg

CDBT

0.00%

avg

7.10%

Payout Ratio▼+12.00% vs sectorBelow avg

CDBT

50.00%

avg

38.00%

Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CDBT sourced from FMP /financial-growth endpoint — real data, not estimates.

🏛️ CDBT Insider Activity

No recent SEC filings reported in the last 90 days.

🔬

Financial Health Scores

Altman Z-Score

-9.38

🔴 Distress Zone — elevated dividend cut risk

Safe: >3.0 · Grey: 1.81–3.0 · Distress: <1.81

Piotroski F-Score

2/9

🔴 Weak fundamentals — dividend safety concern

Strong: 7–9 · Moderate: 4–6 · Weak: 0–3

Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.

📊 About This Data

Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.

🔄 Updated daily🔒 SEC EDGAR source✍️ Reviewed by Victor Strand

📊 Data via FMP🔒 SEC EDGAR🔄 Updated daily✍️ Reviewed by Victor Strand 📬 Report data error

Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CDBT dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →